Skip to main content

Table 1 Clinical characteristics

From: Risk factors of 180-day rebleeding after management of blunt splenic injury without surgery and embolization: a national database study

 

Risk identifying Cohort

Validation Cohort

 

N=

4916

N=

1224

p

Age, median (IQR) y

35.46

(27.50)

38.00

(27.81)

0.324

Sex

     

 Female

1503

30.57%

367

29.98%

0.703

 Male

3413

69.43%

857

70.02%

 

Trauma severity

     

Traffic accident

1882

38.28%

466

38.07%

0.895

Spleen laceration severity

    

0.455

 Hematoma of spleen without laceration

669

13.61%

180

14.71%

 

 Capsular tears without parenchymal injury

289

5.88%

82

6.70%

 

Laceration into parenchyma

429

8.73%

99

8.09%

 

Massive parenchymal disruption

1062

21.60%

275

22.47%

 

 Unspecified splenic injury

2467

50.18%

588

48.04%

 

ISS ≥ 16

512

10.41%

151

12.34%

0.057

Accompanying damage

     

 Intracranial hemorrhage

238

4.84%

55

4.49%

0.653

 Hemothorax

787

16.01%

203

16.58%

0.633

 Blunt hepatic injury

600

12.21%

153

12.50%

0.770

 Blunt renal injury

600

12.21%

153

12.50%

0.770

 Pelvic fracture

212

4.31%

46

3.76%

4.260

 Femoral fracture

182

3.70%

44

3.59%

0.932

 Length of hospitalization, median (IQR)

8

(8)

8

(7)

0.355

Major coexisting disease

     

 Myocardial infarction

18

0.37%

7

0.57%

0.316

 Congestive heart failure

84

1.71%

13

1.06%

0.123

 Vascular disease

23

0.47%

7

0.57%

0.647

 Cerebrovascular disease

137

2.79%

35

2.86%

0.923

 Dementia

7

0.14%

4

0.33%

0.246

 Chronic pulmonary disease

166

3.38%

43

3.51%

0.792

 Rheumatic disease

22

0.45%

5

0.41%

1.000

 Peptic ulcer disease

330

6.71%

81

6.62%

0.949

 Severe liver disease

58

1.18%

16

1.31%

0.663

 Diabetes mellitus

311

6.33%

73

5.96%

0.692

 Hemiplegia

38

0.77%

6

0.49%

0.348

 On dialysis

19

0.39%

2

0.16%

0.408

 Malignancy

138

2.81%

36

2.94%

0.773

 HTN

434

8.83%

112

9.15%

0.736

 Hyperlipidemia

165

3.36%

27

2.21%

0.043*

 Gout

126

2.56%

31

2.53%

1.000

 Obesity

7

0.14%

2

0.16%

0.697

Rebleeding requiring interventions

61

1.24%

19

1.55%

0.398

 Splenectomy

54

88.52%

17

89.47%

1.000

 Transcatheter arterial embolization

7

11.48%

2

10.53%

1.000

 Length of hospitalization, median (IQR)

9

(8)

10

(6)

0.919

 In-hospital mortality

0

0.00%

0

0.00%

 

Duration from discharge

7

(19)

5

(12)

0.667

Duration from the first admission

18

(24)

12

(16)

0.553

  1. * p < 0.05